BLU 554 companion diagnostic - Blueprint Medicines/Ventana Medical Systems

Drug Profile

BLU 554 companion diagnostic - Blueprint Medicines/Ventana Medical Systems

Alternative Names: BLU-554 companion diagnostic - Blueprint Medicines/Ventana Medical Systems

Latest Information Update: 13 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Blueprint Medicines; Ventana Medical Systems
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Hepatocellular carcinoma

Most Recent Events

  • 01 Mar 2016 Blueprint Medicines and Ventana Medical Systems agree to co-develop and co-promote BLU 554 companion diagnostic for Hepatocellular carcinoma (Diagnosis) (3270672; 9222546)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top